Mammen Mathai 4
4 · 10x Genomics, Inc. · Filed Sep 16, 2019
Insider Transaction Report
Form 4
Mammen Mathai
Director
Transactions
- Other
Stock Option (right to buy)
2019-09-16−200,000→ 0 totalExercise: $1.16Exp: 2027-06-12→ Class B Common Stock (200,000 underlying) - Other
Stock Option (right to buy)
2019-09-16+200,000→ 200,000 totalExercise: $1.16Exp: 2027-06-12→ Class A Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering.
- [F2]One forty-eighth of the shares subject to the option vested on July 12, 2017 and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares.